NXP (NXPI) Form 144: Proposed 1,000-Share Sale via Morgan Stanley
Rhea-AI Filing Summary
NXP Semiconductors (NXPI) Form 144 shows a proposed sale of 1,000 common shares to be executed through Morgan Stanley Smith Barney on 09/15/2025 on NASDAQ with an aggregate market value of $216,210.00 and 252,114,595 shares outstanding. The filing itemizes the acquisition of these shares as restricted stock: 533 shares acquired 08/03/2023 and 467 shares acquired 11/01/2023, both from the issuer and paid on acquisition dates. The notice also discloses a prior sale of 1,000 common shares on 06/16/2025 generating gross proceeds of $213,940.00. The signee represents no undisclosed material adverse information and the filing is marked LIVE.
Positive
- Full compliance disclosure under Rule 144 with broker, share count, acquisition history, and sale date provided
- Attestation that the seller does not possess undisclosed material adverse information
Negative
- None.
Insights
TL;DR: Insiders are selling a small block (1,000 shares) of restricted stock via an open-market notice; transaction size is immaterial to market cap.
The Form 144 identifies a proposed 1,000-share sale through Morgan Stanley Smith Barney with an aggregate market value of $216,210, indicating a per-share implied value near the aggregate/quantity ratio shown in the filing. The shares were originally issued as restricted stock in two tranches in 2023 and have been previously sold in an identical 1,000-share transaction on 06/16/2025 producing $213,940. The filing is a routine compliance disclosure under Rule 144 and includes the standard attestation that no undisclosed material adverse information exists.
TL;DR: Filing is a standard insider sale notice with required attestations; no governance red flags are stated.
The document provides the required notice elements: identity of the broker, number of shares to be sold, acquisition history showing restricted stock origin, and a prior recent sale. The signee affirms the absence of undisclosed material adverse information. There are no statements here regarding changes in control, disciplinary actions, or other governance events. As presented, the filing meets Rule 144 disclosure expectations without revealing material governance concerns.